Brian Bressler, MS, MD

University of British Columbia, IBD Centre of BC, Canada

Poster(s):

• P4307 - Corticosteroid Sparing Effects of Treatment With Guselkumab in Patients With Moderate to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results Through Week 44
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET